Zynerba Pharmaceuticals
Why Robinhood?
You can watch ZYNE and buy or sell other stocks, ETFs, and their options commission-free!About ZYNE
Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and development of rare and near-rare neuropsychiatric conditions.
ZYNE Key Statistics
Stock Snapshot
As of today, Zynerba Pharmaceuticals(ZYNE) shares are valued at $1.30. The company's market cap stands at 70.12M, with a P/E ratio of -1.63.
On 2026-05-12, Zynerba Pharmaceuticals(ZYNE) stock opened at —, reached a high of —, and a low of —.
The Zynerba Pharmaceuticals(ZYNE)'s current trading volume is 0, compared to an average daily volume of 585.87K.
In the last year, Zynerba Pharmaceuticals(ZYNE) shares hit a 52-week high of $1.40 and a 52-week low of $0.25.
In the last year, Zynerba Pharmaceuticals(ZYNE) shares hit a 52-week high of $1.40 and a 52-week low of $0.25.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.